Mr Avinash Shivaputrappa Patil, MD | |
4424 E Flamingo Ave Ste 220, Nampa, ID 83687-9289 | |
(208) 302-1100 | |
(208) 302-1155 |
Full Name | Mr Avinash Shivaputrappa Patil |
---|---|
Gender | Male |
Speciality | Obstetrics & Gynecology - Maternal & Fetal Medicine |
Location | 4424 E Flamingo Ave Ste 220, Nampa, Idaho |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1720291024 | NPI | - | NPPES |
Entity Name | East Carolina University |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972551919 PECOS PAC ID: 0244143246 Enrollment ID: O20031106000400 |
News Archive
University of Waterloo researchers have created a tool aimed at decreasing the rate of malnutrition in hospitals.
Five U.S. federal agencies recently cosponsored a set of expert work groups to formulate common data elements for research related to psychological adjustment and traumatic brain injury (TBI).
A study conducted by an inter-professional team of LSU Health Sciences Center New Orleans faculty found that simulation-based operating room team training of medical and nursing students resulted in more effective teamwork by improving attitudes, behaviors, interaction and overall performance leading to potential increased patient safety and better clinical outcomes.
Barcelona, Spain: Researchers in The Netherlands have developed a method of accurately predicting which patients with colon cancer are most likely to have their disease recur after surgery and who would, therefore, be likely to benefit from additional chemotherapy.
In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired - permanently editing a gene, but only temporarily activating CRISPR-Cas9.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Avinash Shivaputrappa Patil, MD Po Box 190930, Boise, ID 83719-0930 Ph: (208) 367-5170 | Mr Avinash Shivaputrappa Patil, MD 4424 E Flamingo Ave Ste 220, Nampa, ID 83687-9289 Ph: (208) 302-1100 |
News Archive
University of Waterloo researchers have created a tool aimed at decreasing the rate of malnutrition in hospitals.
Five U.S. federal agencies recently cosponsored a set of expert work groups to formulate common data elements for research related to psychological adjustment and traumatic brain injury (TBI).
A study conducted by an inter-professional team of LSU Health Sciences Center New Orleans faculty found that simulation-based operating room team training of medical and nursing students resulted in more effective teamwork by improving attitudes, behaviors, interaction and overall performance leading to potential increased patient safety and better clinical outcomes.
Barcelona, Spain: Researchers in The Netherlands have developed a method of accurately predicting which patients with colon cancer are most likely to have their disease recur after surgery and who would, therefore, be likely to benefit from additional chemotherapy.
In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired - permanently editing a gene, but only temporarily activating CRISPR-Cas9.
› Verified 8 days ago
Dr. Linda Kay Walker, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4424 E Flamingo Ave, Ste 200, Nampa, ID 83687 Phone: 208-302-1400 Fax: 208-302-1455 | |
Dr. Juliette Evelyn Hughes, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1611 B 12th Ave Rd, Nampa, ID 83686 Phone: 208-442-8035 Fax: 208-442-8038 | |
Dr. Megan E Kasper, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9850 St Lukes Dr, Nampa, ID 83687 Phone: 208-463-3000 Fax: 208-463-3047 | |
Dr. Justin Bruner, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9850 W St Lukes Dr, Nampa, ID 83687 Phone: 208-381-2267 | |
Ryan Pettit, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4424 E Flamingo, Ste 200, Nampa, ID 83687 Phone: 208-302-1400 Fax: 208-302-1455 | |
Jeffery Reese, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4424 E Flamingo Ave, Ste 200, Nampa, ID 83687 Phone: 208-302-1400 Fax: 208-302-1455 | |
Brennan Anderson, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4424 E Flamingo Ave Ste 200, Nampa, ID 83687 Phone: 208-302-1400 Fax: 208-302-1455 |